Interaction of platelets with subendothelium in humans treated with aspirin and dipyridamole alone or in combination.
D000255:Adenosine Triphosphate / Q000097:blood; D000328:Adult; D000818:Animals; D001012:Aorta, Abdominal / Q000502:physiology*; D001241:Aspirin / Q000494:pharmacology / Q000627:therapeutic use*; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D002918:Chymotrypsin; D004176:Dipyridamole / Q000494:pharmacology / Q000627:therapeutic use*; D004347:Drug Interactions; D004727:Endothelium / Q000502:physiology; D006801:Humans; D008875:Middle Aged; D010973:Platelet Adhesiveness / Q000187:drug effects*; D010974:Platelet Aggregation / Q000187:drug effects*; D011817:Rabbits; D013927:Thrombosis / Q000503:physiopathology / Q000517:prevention & control*
D004176:Dipyridamole; D000255:Adenosine Triphosphate; D002918:Chymotrypsin; D001241:Aspirin